Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
Douglas Marvel(Johnson & Johnson (United States)), Dmitry I. Gabrilovich(AstraZeneca (Netherlands))
Cited by 1,027
Related Papers
Regulation of Tumor Metastasis by Myeloid-Derived Suppressor Cells
|Annual Review of Medicine|2014|505
Classification of current anticancer immunotherapies
|Oncotarget|2014|469
Mechanism of All- <i>Trans</i> Retinoic Acid Effect on Tumor-Associated Myeloid-Derived Suppressor Cells
|Cancer Research|2007|416
Rational design of shepherdin, a novel anticancer agent
|Cancer Cell|2005|347
Immunologic Monitoring of Cancer Vaccine Therapy: Results of a Workshop Sponsored by the Society for Biological Therapy
|Journal of Immunotherapy|2002|299